Marked Chart Marked Chart Closed

The Marked Chart Wire · Business

Tempus AI

Tempus AI partners with Blood Cancer United on pediatric AML data initiative

Tempus AI is collaborating with Blood Cancer United and the Rally Foundation to collect real-world patient data for acute myeloid leukemia. The program uses the Olivia app to organize records and aims to improve clinical trial design for children.

TEM-6.3%

Part of a series: Tempus AI shares trial data and beats earnings estimates

Illustration for the Business desk

The stocks in this story

  1. TEM-6.3%Tempus AI$59.61

Prices from Based on Thu, Nov 19 close · Opens Fri 9:30 AM ET. Each tile opens the stock's chart and news.

New to this? Read: Reading a stock chart

More Business news

Fast headlines, summarized. Not verified and not advice. Check the full story before you act.